Effectiveness and complications of vascular access closure devices after interventional procedures

Marco Sesana, Marco Vaghetti, Remo Albiero, Nicola Corvaja, Giovanni Martini, Ginevra Sivieri, Antonio Colombo

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

Background. Vascular closure devices are designed to obtain a fast hemostasis of the vascular access site after diagnostic and interventional procedures. This result should be obtained with a low incidence of complications. Methods. A retrospective, non-randomized study was performed to evaluate the success rate and vascular complications associated with the use of two different vascular sealing devices [Angio-Seal (Daig Corporation, Minnetonka, Minnesota) and Prostar (Perclose, Inc., Redwood City, California)] after interventional procedures. Results. Eight hundred and twenty-seven devices were used (245 Angio-Seal and 582 Prostar). Angio-Seal success rate was 92% with a 2.5% rate of vascular complications; Prostar success rate was 89% with a 3.4% rate of vascular complications. Multivariate logistic regression analysis identified advanced age (p <0.05) and lower weight (p <0.05) as independent predictors of vascular complications associated with Angio-Seal use, while diabetes (p <0.05) was found to be a predictor of vascular complications in the Prostar group. Abciximab use and larger sheath size were not associated with an increased probability of vascular complications. Conclusion. Angio-Seal and Prostar obtain a fast vascular access hemostasis after interventional procedures, with a low incidence of major vascular complications.

Original languageEnglish
Pages (from-to)395-399
Number of pages5
JournalJournal of Invasive Cardiology
Volume12
Issue number8
Publication statusPublished - Aug 2000

Fingerprint

Vascular Access Devices
Blood Vessels
Hemostasis
Sequoia
Vascular Closure Devices
Equipment and Supplies
Incidence
Logistic Models
Regression Analysis
Weights and Measures

Keywords

  • Hemostasis
  • Percutaneous transluminal coronary angioplasty
  • Peripheral vascular complications
  • Vascular closure devices

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Sesana, M., Vaghetti, M., Albiero, R., Corvaja, N., Martini, G., Sivieri, G., & Colombo, A. (2000). Effectiveness and complications of vascular access closure devices after interventional procedures. Journal of Invasive Cardiology, 12(8), 395-399.

Effectiveness and complications of vascular access closure devices after interventional procedures. / Sesana, Marco; Vaghetti, Marco; Albiero, Remo; Corvaja, Nicola; Martini, Giovanni; Sivieri, Ginevra; Colombo, Antonio.

In: Journal of Invasive Cardiology, Vol. 12, No. 8, 08.2000, p. 395-399.

Research output: Contribution to journalArticle

Sesana, M, Vaghetti, M, Albiero, R, Corvaja, N, Martini, G, Sivieri, G & Colombo, A 2000, 'Effectiveness and complications of vascular access closure devices after interventional procedures', Journal of Invasive Cardiology, vol. 12, no. 8, pp. 395-399.
Sesana M, Vaghetti M, Albiero R, Corvaja N, Martini G, Sivieri G et al. Effectiveness and complications of vascular access closure devices after interventional procedures. Journal of Invasive Cardiology. 2000 Aug;12(8):395-399.
Sesana, Marco ; Vaghetti, Marco ; Albiero, Remo ; Corvaja, Nicola ; Martini, Giovanni ; Sivieri, Ginevra ; Colombo, Antonio. / Effectiveness and complications of vascular access closure devices after interventional procedures. In: Journal of Invasive Cardiology. 2000 ; Vol. 12, No. 8. pp. 395-399.
@article{a1dc5188dab54f25bd85f09d75d23251,
title = "Effectiveness and complications of vascular access closure devices after interventional procedures",
abstract = "Background. Vascular closure devices are designed to obtain a fast hemostasis of the vascular access site after diagnostic and interventional procedures. This result should be obtained with a low incidence of complications. Methods. A retrospective, non-randomized study was performed to evaluate the success rate and vascular complications associated with the use of two different vascular sealing devices [Angio-Seal (Daig Corporation, Minnetonka, Minnesota) and Prostar (Perclose, Inc., Redwood City, California)] after interventional procedures. Results. Eight hundred and twenty-seven devices were used (245 Angio-Seal and 582 Prostar). Angio-Seal success rate was 92{\%} with a 2.5{\%} rate of vascular complications; Prostar success rate was 89{\%} with a 3.4{\%} rate of vascular complications. Multivariate logistic regression analysis identified advanced age (p <0.05) and lower weight (p <0.05) as independent predictors of vascular complications associated with Angio-Seal use, while diabetes (p <0.05) was found to be a predictor of vascular complications in the Prostar group. Abciximab use and larger sheath size were not associated with an increased probability of vascular complications. Conclusion. Angio-Seal and Prostar obtain a fast vascular access hemostasis after interventional procedures, with a low incidence of major vascular complications.",
keywords = "Hemostasis, Percutaneous transluminal coronary angioplasty, Peripheral vascular complications, Vascular closure devices",
author = "Marco Sesana and Marco Vaghetti and Remo Albiero and Nicola Corvaja and Giovanni Martini and Ginevra Sivieri and Antonio Colombo",
year = "2000",
month = "8",
language = "English",
volume = "12",
pages = "395--399",
journal = "Journal of Invasive Cardiology",
issn = "1042-3931",
publisher = "HMP Communications",
number = "8",

}

TY - JOUR

T1 - Effectiveness and complications of vascular access closure devices after interventional procedures

AU - Sesana, Marco

AU - Vaghetti, Marco

AU - Albiero, Remo

AU - Corvaja, Nicola

AU - Martini, Giovanni

AU - Sivieri, Ginevra

AU - Colombo, Antonio

PY - 2000/8

Y1 - 2000/8

N2 - Background. Vascular closure devices are designed to obtain a fast hemostasis of the vascular access site after diagnostic and interventional procedures. This result should be obtained with a low incidence of complications. Methods. A retrospective, non-randomized study was performed to evaluate the success rate and vascular complications associated with the use of two different vascular sealing devices [Angio-Seal (Daig Corporation, Minnetonka, Minnesota) and Prostar (Perclose, Inc., Redwood City, California)] after interventional procedures. Results. Eight hundred and twenty-seven devices were used (245 Angio-Seal and 582 Prostar). Angio-Seal success rate was 92% with a 2.5% rate of vascular complications; Prostar success rate was 89% with a 3.4% rate of vascular complications. Multivariate logistic regression analysis identified advanced age (p <0.05) and lower weight (p <0.05) as independent predictors of vascular complications associated with Angio-Seal use, while diabetes (p <0.05) was found to be a predictor of vascular complications in the Prostar group. Abciximab use and larger sheath size were not associated with an increased probability of vascular complications. Conclusion. Angio-Seal and Prostar obtain a fast vascular access hemostasis after interventional procedures, with a low incidence of major vascular complications.

AB - Background. Vascular closure devices are designed to obtain a fast hemostasis of the vascular access site after diagnostic and interventional procedures. This result should be obtained with a low incidence of complications. Methods. A retrospective, non-randomized study was performed to evaluate the success rate and vascular complications associated with the use of two different vascular sealing devices [Angio-Seal (Daig Corporation, Minnetonka, Minnesota) and Prostar (Perclose, Inc., Redwood City, California)] after interventional procedures. Results. Eight hundred and twenty-seven devices were used (245 Angio-Seal and 582 Prostar). Angio-Seal success rate was 92% with a 2.5% rate of vascular complications; Prostar success rate was 89% with a 3.4% rate of vascular complications. Multivariate logistic regression analysis identified advanced age (p <0.05) and lower weight (p <0.05) as independent predictors of vascular complications associated with Angio-Seal use, while diabetes (p <0.05) was found to be a predictor of vascular complications in the Prostar group. Abciximab use and larger sheath size were not associated with an increased probability of vascular complications. Conclusion. Angio-Seal and Prostar obtain a fast vascular access hemostasis after interventional procedures, with a low incidence of major vascular complications.

KW - Hemostasis

KW - Percutaneous transluminal coronary angioplasty

KW - Peripheral vascular complications

KW - Vascular closure devices

UR - http://www.scopus.com/inward/record.url?scp=0034243095&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034243095&partnerID=8YFLogxK

M3 - Article

C2 - 10953101

AN - SCOPUS:0034243095

VL - 12

SP - 395

EP - 399

JO - Journal of Invasive Cardiology

JF - Journal of Invasive Cardiology

SN - 1042-3931

IS - 8

ER -